These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24410781)

  • 1. EAACI position statement on asthma exacerbations and severe asthma.
    Custovic A; Johnston SL; Pavord I; Gaga M; Fabbri L; Bel EH; Le Souëf P; Lötvall J; Demoly P; Akdis CA; Ryan D; Mäkelä MJ; Martinez F; Holloway JW; Saglani S; O'Byrne P; Papi A; Sergejeva S; Magnan A; Del Giacco S; Kalayci O; Hamelmann E; Papadopoulos NG
    Allergy; 2013 Dec; 68(12):1520-31. PubMed ID: 24410781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbations of severe asthma.
    McDonald VM; Gibson PG
    Clin Exp Allergy; 2012 May; 42(5):670-7. PubMed ID: 22515389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions.
    Bourdin A; Bjermer L; Brightling C; Brusselle GG; Chanez P; Chung KF; Custovic A; Diamant Z; Diver S; Djukanovic R; Hamerlijnck D; Horváth I; Johnston SL; Kanniess F; Papadopoulos N; Papi A; Russell RJ; Ryan D; Samitas K; Tonia T; Zervas E; Gaga M
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31467120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe asthma in children: Evaluation and management.
    Haktanir Abul M; Phipatanakul W
    Allergol Int; 2019 Apr; 68(2):150-157. PubMed ID: 30648539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.
    Kapoor M; Storrar W; Balls L; Brown TP; Mansur A; Hedley E; Jones T; Roberts C; Shirkey B; Dutton S; Luengo-Fernandez R; Little M; Dewey A; Marshall S; Fogg C; Boughton K; Rahman N; Yu LM; Bradding P; Howarth P; Chauhan AJ
    Health Technol Assess; 2019 Jun; 23(29):1-140. PubMed ID: 31232684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
    National Asthma Education and Prevention Program
    J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
    Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
    Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergy in severe asthma.
    Del Giacco SR; Bakirtas A; Bel E; Custovic A; Diamant Z; Hamelmann E; Heffler E; Kalayci Ö; Saglani S; Sergejeva S; Seys S; Simpson A; Bjermer L
    Allergy; 2017 Feb; 72(2):207-220. PubMed ID: 27775836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provider adherence to a clinical practice guideline for acute asthma in a pediatric emergency department.
    Scribano PV; Lerer T; Kennedy D; Cloutier MM
    Acad Emerg Med; 2001 Dec; 8(12):1147-52. PubMed ID: 11733292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade disease activity in early life precedes childhood asthma and allergy.
    Chawes BL
    Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma control assessment in a pediatric population: comparison between GINA/NAEPP guidelines, Childhood Asthma Control Test (C-ACT), and physician's rating.
    Deschildre A; Pin I; El Abd K; Belmin-Larrar S; El Mourad S; Thumerelle C; Le Roux P; Langlois C; de Blic J
    Allergy; 2014 Jun; 69(6):784-90. PubMed ID: 24725204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruses in asthma exacerbations.
    Tan WC
    Curr Opin Pulm Med; 2005 Jan; 11(1):21-6. PubMed ID: 15591884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.
    Norman G; Faria R; Paton F; Llewellyn A; Fox D; Palmer S; Clifton I; Paton J; Woolacott N; McKenna C
    Health Technol Assess; 2013 Nov; 17(52):1-342. PubMed ID: 24267198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights and recent developments in airway diseases in EAACI journals (2018).
    Bousquet J; Akdis CA; Grattan C; Eigenmann PA; Hoffmann-Sommergruber K; Agache I; Jutel M
    Allergy; 2019 Dec; 74(12):2329-2341. PubMed ID: 31573676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and Treatment of Asthma Exacerbations in Adults.
    Menzies-Gow A; Busse WW; Castro M; Jackson DJ
    J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2578-2586. PubMed ID: 34246434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in asthma 2015: Across the lifespan.
    Liu AH; Anderson WC; Dutmer CM; Searing DA; Szefler SJ
    J Allergy Clin Immunol; 2016 Aug; 138(2):397-404. PubMed ID: 27497278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term future risk of severe exacerbations: Distinct 5-year trajectories of problematic asthma.
    Yii ACA; Tan JHY; Lapperre TS; Chan AKW; Low SY; Ong TH; Tan KL; Chotirmall SH; Sterk PJ; Koh MS
    Allergy; 2017 Sep; 72(9):1398-1405. PubMed ID: 28295424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japanese guidelines for adult asthma 2017.
    Ichinose M; Sugiura H; Nagase H; Yamaguchi M; Inoue H; Sagara H; Tamaoki J; Tohda Y; Munakata M; Yamauchi K; Ohta K;
    Allergol Int; 2017 Apr; 66(2):163-189. PubMed ID: 28196638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and prevention strategies of severe asthma exacerbations in children.
    Cook J; Saglani S
    Curr Opin Pulm Med; 2016 Jan; 22(1):25-31. PubMed ID: 26574720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.
    Burch J; Griffin S; McKenna C; Walker S; Paton J; Wright K; Woolacott N
    Pharmacoeconomics; 2012 Nov; 30(11):991-1004. PubMed ID: 22950547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.